Abstract
Purpose
Mitomycin C is a routinely used antimetabolite which effectively limits the scarring process. Conventionally, the intra-operative technique of MMC delivery during trabeculectomy is the direct application of the soaked sponges. The aim of this study is to evaluate the current practice of delivering MMC during trabeculectomy and to see the practices related to a retained MMC swab during trabeculectomy in the UK.
Methods
An electronic questionnaire of 8 questions regarding the intraoperative use of MMC during trabeculectomy surgery was emailed to 69 ophthalmologist members of the UK and Eire glaucoma society (UKEGS) through email in July 2019.
Results
97.2% of the surveyed glaucoma surgeons said they use MMC during trabeculectomy routinely, while 2.9% said they never use MMC for trabeculectomy. In reply to a question ‘Have you ever had a retained MMC-soaked sponge/fragment of sponge’, 11.76% replied ‘yes’, 88.24% said ‘No’. In response to what technique was employed at the time of retained MMC sponges, all the respondents said they had employed the same technique of ‘multiple individual sponges’. 47.1% surgeons said they use multiple individual sponges on being asked what technique they currently employ for delivering MMC during trabeculectomy surgery, while 14.7% surgeons use multiple sponges linked with a ‘necklace suture’ and 5.9% inject MMC.
Conclusion
Our survey suggests the intra-operative MMC use in the UK is high and that unintentional MMC-soaked swab retention does occur, albeit rarely. A preference of using the MMC-soaked swabs as a delivery method of MMC is seen in our survey.
Similar content being viewed by others
Data Availability
The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.
References
Cairns JE (1968) Trabeculectomy. Preliminary report of a new method. Am J Ophthalmol 66:673–679
Fontana H, Nouri-Mahdavi K, Lumba J, Ralli M, Caprioli J (2006) Trabeculectomy with mitomycin C: outcomes and risk factors for failure in phakic open-angle glaucoma. Ophthalmology 113:930–936
Singh K (1997) Antimetabolite application: science or voodoo? J Glaucoma 6:271–273
Chen CW (1983) Enhanced intraocular pressure controlling effectiveness of trabeculectomy by local application of mitomycin C. Trans Asia-Pacific Acad Ophthalmol 9:172–177
Falck FY Jr, Skuta GL et al (1992) Mitomycin vs 5-fluoruracil anti-metabolite therapy for glaucoma filtration surgery. Semin Ophthalmol 7:97–109
Sisto D, Vetrugno M et al (2007) The role of antimetabolites in filtration surgery for neovascular glaucoma: intermediate-term follow-up. Acta Ophthalmol Scand 85(3):267–271
Edmunds B, Thompson J, Salmon J et al (2001) The National Survey of Trabeculectomy. II. Variations in operative technique and outcome. Eye 15:441–448
Siriwardena D, Edmunds B, Wormald RPL et al (2004) National survey of antimetabolite use in glaucoma surgery in the United Kingdom. Br J Ophthalmol 88:873–876
Agarwal HC, Saigal D, Sihota R (2001) Assessing the role of subconjunctival versus intrascleral application of mitomycin-C in high-risk trabeculectomies. Indian J Ophthalmol 49(2):91–95
Tressler CS, Cyrlin MN, Rosenshein JS, Fazio R (1996) Subconjunctival versus intrascleral mitomycin-C in trabeculectomy. Ophthalmic Surg Lasers 27:661–666
Singh J, O’Brien C, Chawla HB (1995) Success rate and complications of intraoperative 0.2 mg/ml mitomycin C in trabeculectomy surgery. Eye (Lond). 9(Pt 4):460–466
Choudhary S, Sen S, Gupta O (2018) An unusual case of post trabeculectomy conjunctival granuloma. Oman J Ophthalmol 11:52–54
Khamar M, Bhojwani D, Patel P, Vasavada A (2019) Leftover mitomycin-c sponge causing blebitis. Indian J Ophthalmol 67(10):1753–1755
Al-Shahwan S, Edward DP (2005) Foreign body granulomas secondary to retained sponge fragment following mitomycin C trabeculectomy. Graefes Arch Clin Exp Ophthalmol 243(2):178–181
Shin DH, Tsai CS, Kupin TH, Olivier MM (1994) Retained cellulose sponge after trabeculectomy with adjunctive subconjunctival mitomycin C. Am J Ophthalmol 118:111–112
Laura L (2012) "Surgeons Make Thousands of Snafus", Wall Street J, p A2, retrieved 12 October 2013
Improvement.nhs.uk. 2020. Revised Never Events Policy And Framework | NHS Improvement. [online] Available at: https://improvement.nhs.uk/resources/never-events-policy-and-framework/
Urbaneja D, Morilla-Grasa A, Jimenez E et al (2016) In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery. Clin Ophthalmol 10:665–669
Poole TR, Gillespie IH, Knee G, Whitworth J (2002) Microscopic fragmentation of ophthalmic surgical sponge spears used for delivery of antiproliferative agents in glaucoma filtering surgery. Br J Ophthalmol 86(12):1448–1449. https://doi.org/10.1136/bjo.86.12.1448
Lindfield D, Jutley G, Griffiths M (2010) Trabeculectomy pearls of wisdom; mitomycin-soaked pledget ‘necklace’ suture. Eye 24:1307–1308
Melo AB, Spaeth GL (2010) A new, safer method of applying antimetabolites during glaucoma filtering surgery. Ophthalmic Surg Lasers Imaging 41(3):383–385
Maheshwari D, Kanduri S, Rengappa R, Kadar MA (2020) Intraoperative injection versus sponge-applied mitomycin C during trabeculectomy: One-year study. Indian J Ophthalmol 68(4):615–619
Khouri AS, Huang G, Huang LY (2017) Intraoperative Injection versus Sponge-applied Mitomycin C during Trabeculectomy: one-year study. J Curr Glaucoma Pract 11(3):101–106
Guimarães MEV et al (2019) Glaucoma surgery with soaked sponges with mitomycin c vs sub-tenon injection: Short-term outcomes. J Curr Glaucoma Pract 13(2):50–54
Esfandiari H et al (2018) Treatment outcomes of mitomycin C-augmented trabeculectomy, sub-tenon injection versus soaked sponges, after 3 years of follow-up. Ophthalmol Glaucoma 1(1):66–74
Funding
Authors did not receive any funding for this survey.
Author information
Authors and Affiliations
Contributions
SAK was involved in concept, design, write-up and approval of the final manuscript draft. KW was involved in idea, concept, design and write-up approval of the final manuscript draft. MAR was involved in design, manuscript drafting and approval of the final manuscript draft. URA was involved in design, data analysis, manuscript drafting and approval of the final manuscript draft.
Corresponding author
Ethics declarations
Conflict of interests
The authors declare that there is no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors and therefore does not require an ethical committee approval.
Informed consent
Informed consent obtained from all the participants of this survey study.
Animal Research
Not applicable as no animals were involved.
Consent to participate
Informed consent obtained from the participants.
Clinical Trials Registration
Not applicable as this study was a surgeon survey and not a clinical trial.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix
Appendix
-
1.
How often do you use mitomycin C (MMC) in a trabeculectomy surgery?
i | Never | □ |
ii | Less than 25% cases | □ |
iii | Between 25–50% cases | □ |
Iv | More than half of the cases | □ |
If you have answered “Never”, then please DO NOT answer any other questions and click Finish Survey at the bottom of the page. In case of any other answers please continue to question 2 below:
-
2.
Have you ever had a retained MMC-soaked sponge/fragment of sponge?
If you select "yes" please answer all remaining questions.
If you select "no" please go to question 6.
Y | □ |
N | □ |
-
3.
What technique did you employ at the time?
Multiple individual sponges | □ |
Corneal light-shield cut in half/quarter | □ |
Multiple sponges linked with a ‘necklace’ suture | □ |
Others (please specify): | □ |
-
4.
What sponge material did you use at the time?
Polyvinyl alcohol (PVA) | □ |
Methylcellulose | □ |
Absorbable gelatine sponges(AGS) | □ |
Other (please specify): | □ |
-
5.
What size of sponge material did you use at the time?
1 × 1 mm | □ |
2 × 1 mm | □ |
3 × 1 mm | □ |
Others: (please specify) | □ |
-
6.
What technique do you currently employ?
Multiple individual sponges | □ |
Corneal light-shield cut in half/quarter | □ |
Multiple sponges linked with a ‘necklace’ suture | □ |
Inject MMC subconjunctivally instead of using sponges | □ |
Other: (please specify if technique not described above) | □ |
-
7.
What sponge material do you currently employ?
PVA | □ |
Methylcellulose | □ |
AGS | □ |
Other: (please specify) | □ |
-
8.
What sponge size do you currently employ?
1 × 1 mm | □ |
2 × 1 mm | □ |
3 × 1 mm | □ |
Other: (please specify) | □ |
Rights and permissions
About this article
Cite this article
Khan, S.A., Whittaker, K., Razzaq, M.A. et al. National survey of intraoperative mitomycin C use during trabeculectomy surgery in the UK. Int Ophthalmol 41, 1309–1316 (2021). https://doi.org/10.1007/s10792-020-01688-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-020-01688-8